	ERG expression in BPH vs prostatic adenocarcinoma and its correlation with Gleason grade group. J Pak Med Assoc Qayyum M, Shawana S, Nomani BH, Khaliq E, Jamal N, Qayyum H. PMID: 41830348 [PubMed - indexed for MEDLINE]
	Serum Chemokines CCL3 and CCL7 as Complementary Diagnostic Biomarkers Across Tumor Grades in Clear Cell Renal Cell Carcinoma. Int J Mol Sci Sokólska W, Zajkowska M, Kulczy, Werel T, Orywal K. PMID: 41828706 [PubMed - indexed for MEDLINE]
	Impact of Heterogeneous DNA Methylation on the Accuracy of Quantitative Methylation-Specific PCR for Detecting DNA Hypermethylation in Prostate Cancer. Int J Mol Sci Visser WCH, de Jong H, Janssen LB, Shrivastava J, Mulders PFA, Schalken JA, Melchers WJG. PMID: 41828470 [PubMed - indexed for MEDLINE]
	Use of Artificial Intelligence Model Associated with Masson's Trichrome Staining as a Predictor of Muscle Invasion in Bladder Cancer. Int J Mol Sci Parrao D, Gallegos H, Ruz K, Lay R, Saavedra C, Guerrero R, Larrañaga M, Lindsay CB, Bravo JC. PMID: 41828460 [PubMed - indexed for MEDLINE]
	Updates on Clinical Trials and Molecular Characteristics of Locally Advanced and Oligometastatic Renal Cell Carcinoma. Int J Mol Sci Ogunmola TM, Jin Z, Kleberg J, Tithi TI, Anvar S, Maharjan CK, Chatzkel JA, Falzarano SM, Kolb R, Kim MC, Zhang W. PMID: 41828416 [PubMed - indexed for MEDLINE]
	Clinical Utility of PROSTest: A Prospective Study Suggesting Reduction in Unnecessary MRI and Biopsy in Men Evaluated for Prostate Cancer. Cancers (Basel) Rahbar K, Bögemann M, Papavasilis P, Halim A, Kidd M. PMID: 41827804 [PubMed]
	Reirradiation of Local Recurrences of Prostate Cancer: PROSTARE (PROstate Cancer STereotActic REirradiation) Early Safety Analysis of a Phase 2 Study with a Limited Cohort. Cancers (Basel) Majewski W, Napieralska A, Miszczyk M, Misiorowska-Go, Krzempek M, St, Rembak-Szynkiewicz J, Wydma. PMID: 41827781 [PubMed]
	mpMRI-Based Risk Estimation to Optimize Prostate Cancer Patient Selection for Active Surveillance. Cancers (Basel) Wallaengen V, Zacharaki EI, Alhusseini M, Breto AL, Kimbel IM, Soodana-Prakash N, Algohary A, Lowry N, Xu IRL, Freitas PF, Gaston SM, Castillo Acosta RP, Kryvenko ON, Ritch CR, Nahar B, Gonzalgo ML, Parekh DJ, Pollack A, Punnen S, Stoyanova R. PMID: 41827775 [PubMed]
	Laser Energy Application in Endoscopic Kidney-Sparing Surgery for Upper Tract Urothelial Carcinoma: A Systematic Review of Oncological Outcomes and Surgical Complications. Cancers (Basel) Zorzi F, Scilipoti P, Moretto S, Gonzalez-Gonzalez C, Nannola N, Robesti D, Folcia A, Chicaud M, Kutchukian S, Candela L, Laurent B, Ventimiglia E, Montorsi F, Briganti A, Salonia A, Villa L, Doizi S, Traxer O, Panthier F. PMID: 41827753 [PubMed]
	VEGF-TKI Outcomes in Metastatic Renal Cell Carcinoma According to Prior Immune Checkpoint Inhibitor or VEGF-TKI: A Scoping Review and Exploratory Analysis. Cancers (Basel) Nally E, Jovaisaite A, Coca Membribes S, Priyadarshini G, Graham C, MacDonald A, Jackson-Spence F, Szabados B, Powles T. PMID: 41827741 [PubMed]
	Liquid Biopsy in Non-Metastatic Prostate Cancer: Clinical Evidence and Future Directions. Cancers (Basel) Sighinolfi MC, Pallotta G, Del Re M, Moosavi K, Schubert O, Rossi F, Gavi F, Assumma S, Panio E, Totaro A, Turri F, Ragonese M, Foschi N, Russo P, Patel E, Gandi C, Palermo G, Scarciglia E, Pinto F, Presutti S, Moschovas MC, Minucci A, Iacovelli R, Ciccarese C, Tagliaferri L, Pierconti F, Nero C, Zannoni GF, Rocco B. PMID: 41827734 [PubMed]
	Bioactive Natural Products Targeting Androgen Receptor Signaling in Prostate Cancer: A Systematic Review. Cancers (Basel) Pratama F, Novitasari D, Mardianingrum R, Holik HA, Ikram NKK, Muchtaridi M. PMID: 41827723 [PubMed]
	Radiomics-Based Characterization of Aggressive Prostate Cancer Variants: Diagnostic Challenges and Opportunities. Cancers (Basel) Sklinda K, Rajca M, Kasprowicz M, Micha, Ma, Olczak B, Walecki J. PMID: 41827718 [PubMed]
	Impact of the Micropapillary Variant in Urothelial Carcinoma of the Bladder-A Comprehensive Review of Meta-Analyses and Contemporary Cohort Studies. Cancers (Basel) Le, Bocianowski J. PMID: 41827666 [PubMed]
	Mechanisms, Management and Prognosis of Paraneoplastic Hypercalcemia in Penile Squamous Cell Carcinoma: A Structured Review. J Clin Med Andre, Gîngu C, Oli, Dobra MA, Sorohan BM, Obri, Georgescu DE, Eftimie MA, Sinescu I. PMID: 41827227 [PubMed]
	Prostate cancer and CAR-T therapy: a systematic review. BMC Cancer Hakem Zadeh F, Shah N, Bird V. PMID: 41826891 [PubMed - as supplied by publisher]
	HMGB1, An Autophagy-Associated Gene, as a Novel Non-Invasive Diagnostic Biomarker: Clinicopathologic Correlation in Urinary Bladder Carcinoma Patients. Ann Surg Oncol Data S, Trivedi S, Singh Y, Kumar U, Kumar L, Shankhwar SN, Srivastava A, Kumar A, Kar AG, Singh R, Zarekar R. PMID: 41826518 [PubMed - as supplied by publisher]
	Clinical Trial Protocol for the Apa/Enza-short Study: A Randomized Nationwide Study of Shortened 12-Month Duration of Androgen Receptor Signaling Agent in Combination With Androgen Deprivation Therapy in Patients With Metastatic Low-volume Castration-sensitive Prostate Cancer. Eur Urol Focus Hamidikia M, van Dijk TC, Martens JWM, Isebia KT, de Wit R, Beije N. PMID: 41826123 [PubMed - as supplied by publisher]
	The Staging of High-risk And non-metastatic Renal cell carcinoma Preoperatively (SHARP) Model predicts pathologic T3 stage for neoadjuvant clinical trial enrollment. Urology Lotan P, Wentland AL, Shapiro DD, Smith MR, Roadman DF, Allen GO, Jarrard DF, Nichols K, Risk MC, Richards KA, Koehne EL, Jason Abel E. PMID: 41825786 [PubMed - as supplied by publisher]
	Multidisciplinary therapy managements in endometrial and renal cancer patients treated with pembrolizumab and lenvatinib: a virtuous circle between oncologists and organ specialists. Crit Rev Oncol Hematol Sabbatini R, Cosmai L, De Leo S, Ianiro G, Luppi F, Spallarossa P, Vacchi C, Porta C. PMID: 41825579 [PubMed - as supplied by publisher]

Articles 1 - 20 / 176806

Page 1 of 8841



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy